Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Feb 2;103(5):e36831.
doi: 10.1097/MD.0000000000036831.

The impact of BMI on breast cancer - an updated systematic review and meta-analysis

Affiliations
Meta-Analysis

The impact of BMI on breast cancer - an updated systematic review and meta-analysis

Nikolaos Tzenios et al. Medicine (Baltimore). .

Abstract

Background: Breast cancer is the most frequent form of cancer in women all over the world. It is the main cause of cancer death and the most often diagnosed cancer in women in 140 of the world's 184 countries. The link between breast cancer risk and body mass index (BMI) has gotten increasing attention in recent years, although the results are still debatable. Therefore, the current systematic review and meta-analysis evaluate the impact of BMI on breast cancer.

Methods: The current study was carried out as a systematic review and meta-analysis, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We systematically searched Cochrane, Google Scholar, PubMed, EMBASE and Scopus databases to identify eligible articles impact of BMI on breast cancer with the appropriate Medical Subject Headings (MeSH). The Newcastle-Ottawa checklist was used for the risk of assessment for the included studies. Meta-analysis was performed using Review Manager 5.3 software.

Results: Forty-six studies were included in the current review, which met the selection criteria of the current review. Among included 46 studies in this review, 50% (n = 23) of the studies found the HER2 type of breast cancer followed by triple-negative and HR-positive. The obesity was significantly higher in the case group compared with the control group (P < .001). Heterogeneity between the 14 studies is medium (I2 = 72%). In this review, there was no significant relation between overweight and breast cancer in women (P > .05). Heterogenecity between the 14 studies is medium (I2 = 89%). However, after removing the publication bias a significant relation between overweightness and breast cancer in women (P = .0005) was observed.

Conclusion: Obese breast cancer patients are a specific type of patient. They are more likely to develop cancer. Their need to surgery and radiation may cause greater difficulties. Obesity and overweight in women greatly increase the risk of breast cancer, according to the findings of the current meta-analysis. To confirm these findings and understand the pathogenic pathways, more research is required.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
PRISMA chart.
Figure 2.
Figure 2.
Funnel plot of odds ratio estimates of breast cancer by obesity.
Figure 3.
Figure 3.
Forest plot of odds ratio estimates of breast cancer by obesity.
Figure 4.
Figure 4.
Funnel plot of odds ratio estimates of breast cancer by obesity after removing studies which lies outside the funnel.
Figure 5.
Figure 5.
forest plot of odds ratio estimates of breast cancer by obesity after removing studies which lies outside the funnel.
Figure 6.
Figure 6.
Funnel plot of odds ratio estimates of breast cancer by overweight.
Figure 7.
Figure 7.
Forest plot of odds ratio estimates of breast cancer by overweight.
Figure 8.
Figure 8.
Funnel plot of odds ratio estimates of breast cancer by overweight after removing studies which lies outside the funnel.
Figure 9.
Figure 9.
Forest plot of odds ratio estimates of breast cancer by overweight after removing studies which lies outside the funnel.

References

    1. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019;11:151–64. - PMC - PubMed
    1. Ram Kumar A, Rajagopal K, Meenambiga SS, et al. In vitro and in silico anti-breast cancer analysis of bioactive metabolites of bacillus subtilis isolated from soil. Saudi J Pathol Microbiol. 2020;05:220–9.
    1. Zahmatkesh BH, Alavi N, Keramat A, et al. Body mass index and risk of breast cancer: a systematic review and meta-analysis in Iran. Int J Cancer Manag. 2017;10. Available at: https://sites.kowsarpub.com/ijcm/articles/5921.html.
    1. Sun Y-S, Zhao Z, Yang Z-N, et al. Risk factors and preventions of breast cancer. Int J Biol Sci. 2017;13:1387–97. - PMC - PubMed
    1. DeSantis CE, Fedewa SA, Goding Sauer A, et al. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66:31–42. - PubMed